These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31371930)

  • 1. Different durations of cognitive stimulation therapy for Alzheimer's disease: a systematic review and meta-analysis.
    Chen J; Duan Y; Li H; Lu L; Liu J; Tang C
    Clin Interv Aging; 2019; 14():1243-1254. PubMed ID: 31371930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychosocial interventions for Alzheimer's disease cognitive symptoms: a Bayesian network meta-analysis.
    Duan Y; Lu L; Chen J; Wu C; Liang J; Zheng Y; Wu J; Rong P; Tang C
    BMC Geriatr; 2018 Aug; 18(1):175. PubMed ID: 30086714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive stimulation therapy for Alzheimer's disease: the effect of cognitive stimulation therapy on the progression of mild Alzheimer's disease in patients treated with donepezil.
    Matsuda O
    Int Psychogeriatr; 2007 Apr; 19(2):241-52. PubMed ID: 17005066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whether cognitive behavioral therapy is effective for Alzheimer's disease: A protocol for systematic review and network meta-analysis.
    Chen WQ; Wu FF; Lv HB; Xing WT; Liu Q; Liu JP; Ge YG; Lu YQ
    Medicine (Baltimore); 2021 Jan; 100(1):e23945. PubMed ID: 33429752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Effectiveness of 3 Settings of Cognitive Stimulation Therapy on Cognition and Quality of Life for People With Dementia: A Systematic Review and Network Meta-analysis.
    Sun Y; Zhang X; Wang Z
    J Am Med Dir Assoc; 2022 Mar; 23(3):461-467.e11. PubMed ID: 34942157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of nonpharmacologic therapy on global cognitive functions in patients with Alzheimer's disease: an updated meta-analysis of randomized controlled trials.
    Wei S; Mai Y; Peng W; Ma J; Sun C; Li G; Liu Z
    Int J Neurosci; 2020 Jan; 130(1):28-44. PubMed ID: 31251099
    [No Abstract]   [Full Text] [Related]  

  • 7. Current treatment of mild cognitive impairment and Alzheimer's disease.
    Knopman DS
    Curr Neurol Neurosci Rep; 2006 Sep; 6(5):365-71. PubMed ID: 16928345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repetitive transcranial magnetic stimulation (rTMS) combined with cognitive training is a safe and effective modality for the treatment of Alzheimer's disease: clinical experience.
    Rabey JM; Dobronevsky E
    J Neural Transm (Vienna); 2016 Dec; 123(12):1449-1455. PubMed ID: 27631152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repetitive Transcranial Magnetic Stimulation as an Alternative Therapy for Cognitive Impairment in Alzheimer's Disease: A Meta-Analysis.
    Liao X; Li G; Wang A; Liu T; Feng S; Guo Z; Tang Q; Jin Y; Xing G; McClure MA; Chen H; He B; Liu H; Mu Q
    J Alzheimers Dis; 2015; 48(2):463-72. PubMed ID: 26402010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rivastigmine for Alzheimer's disease.
    Birks JS; Grimley Evans J
    Cochrane Database Syst Rev; 2015 Apr; (4):CD001191. PubMed ID: 25858345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Aerobic Exercise on Cognitive Function in People with Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Zhang S; Zhen K; Su Q; Chen Y; Lv Y; Yu L
    Int J Environ Res Public Health; 2022 Nov; 19(23):. PubMed ID: 36497772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-Term Response is not Predictive of Long-Term Response to Acetylcholinesterase Inhibitors in Old Age Subjects with Alzheimer's Disease: A "Real World" Study.
    Boccardi V; Baroni M; Smirne N; Clodomiro A; Ercolani S; Longo A; Ruggiero C; Bruni AC; Mecocci P
    J Alzheimers Dis; 2017; 56(1):239-248. PubMed ID: 27911323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
    Rolinski M; Fox C; Maidment I; McShane R
    Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD006504. PubMed ID: 22419314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model.
    Bond M; Rogers G; Peters J; Anderson R; Hoyle M; Miners A; Moxham T; Davis S; Thokala P; Wailoo A; Jeffreys M; Hyde C
    Health Technol Assess; 2012; 16(21):1-470. PubMed ID: 22541366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of metrifonate on the cognitive, behavioral, and functional performance of Alzheimer's disease patients. Metrifonate Study Group.
    Raskind MA; Cyrus PA; Ruzicka BB; Gulanski BI
    J Clin Psychiatry; 1999 May; 60(5):318-25. PubMed ID: 10362441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The comparative efficacy and safety of cholinesterase inhibitors in patients with mild-to-moderate Alzheimer's disease: a Bayesian network meta-analysis.
    Kobayashi H; Ohnishi T; Nakagawa R; Yoshizawa K
    Int J Geriatr Psychiatry; 2016 Aug; 31(8):892-904. PubMed ID: 26680338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the cognitive stimulation therapy based on Roy's adaptation model on Alzheimer's patients' cognitive functions, coping-adaptation skills, and quality of life: A randomized controlled trial.
    Lok N; Buldukoglu K; Barcin E
    Perspect Psychiatr Care; 2020 Jul; 56(3):581-592. PubMed ID: 31930518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive stimulation therapy in the Italian context: its efficacy in cognitive and non-cognitive measures in older adults with dementia.
    Capotosto E; Belacchi C; Gardini S; Faggian S; Piras F; Mantoan V; Salvalaio E; Pradelli S; Borella E
    Int J Geriatr Psychiatry; 2017 Mar; 32(3):331-340. PubMed ID: 27272538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of physical activity and exercise on the cognitive function of patients with Alzheimer disease: a meta-analysis.
    Jia RX; Liang JH; Xu Y; Wang YQ
    BMC Geriatr; 2019 Jul; 19(1):181. PubMed ID: 31266451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metrifonate for Alzheimer's disease.
    López-Arrieta JM; Schneider L
    Cochrane Database Syst Rev; 2006 Apr; (2):CD003155. PubMed ID: 16625573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.